Differentiation of human monocytes in vitro following exposure to canova in the absence of cytokines

Ultrastructural Pathology

Volumn 32, Issue 4, 2008, Pages 147-152

  Smit, Eureke ^a   Pretorius, Etheresia ^a,c   Anderson, Ronald ^a,b   Oommen, Joyce ^a,b   Potjo, Moliehi ^a,b  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^c UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Canova; Cytokines; Dendritic cells; Human monocytes; Macrophages

Indexed keywords

B7 ANTIGEN; CANOVA; CD14 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; GLYCOPROTEIN P 15095; HLA DR ANTIGEN; HOMEOPATHIC AGENT; T6 ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL SPREADING; CELL ULTRASTRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE ACTIVATION; MONOCYTE; PERIPHERAL CIRCULATION; PHENOTYPE; PRIORITY JOURNAL; PSEUDOPODIUM; SCANNING ELECTRON MICROSCOPY;

ANTIGENS, CD; CELL ADHESION; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; CROTALID VENOMS; CYTOKINES; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; FORMULARIES, HOMEOPATHIC; HUMANS; IMMUNOLOGIC FACTORS; MACROPHAGES; MICROSCOPY, ELECTRON, SCANNING; MONOCYTES; PLANT EXTRACTS;

EID: 49449106332     PISSN: 01913123     EISSN: 15210758     Source Type: Journal    
DOI: 10.1080/01913120802062729     Document Type: Article

References (22)

1. Da Rocha Piemonte M, De Freitas Buchi D. Analysis of IL-2, IFN-γ and TNF-α production, α5β1 integrins and actin filaments distribution in peritoneal mouse macrophages treated with homeopathic medicament. J Submicrosc Cytol Pathol. 2002;34:255-263.
2. Pereira WKV, Lonardoni MVC, Grespan R, Caparroz-Assef SM, Cuman RKN, Bersani-Amado CA. Immunomodulatory effect of Canova medication on experimental Leishmania amazonensis infection. J Infect. 2005;51:157-168.
3. De Oliveira CC, De Oliveira SM, Godoy LMF, Gabardo J, De Freitas Buchi D. Canova, a Brazilian medical formulation, alters oxidative metabolism of mice macrophages. J Infect. 2006;52:420-432.
4. Seligmann IC, Lima PDL, Cardoso PCS, et al. The Canova Method homeopathic compound is not genotoxic to the in vitro human lymphocytes. Genet Mol Res. 2003;2:223-228.
5. Lopes L, Godoy LMF, de Oliveira CC, Gabardo J, Schadeck RJG, De Freitas Buchi D. Phagocytosis, endosomal/lysosomal system and other cellular aspects of macrophage activation by Canova medication. Micron. 2006;37:277-287.
6. Sato D, Wal R, de Oliveira CC, et al. Histopathological and immunophenotyping studies on normal and sarcoma 180-bearing mice treated with a complex homeopathic medication. Homeopathy. 2005;94:26-32.
7. Syme R, Bajwa R, Robertson L, Steward D, Glück S. Comparison of CD34 and monocyte-derived dendritic cells from mobilized peripheral blood from cancer patients. Stem Cells. 2005;23:74-81.
8. Fujihara M, Takahashi TA, Azuma M, et al. Decreased inducible expression of CD80 and CD86 in human monocytes after ultraviolet-B irradiation: its involvement in iactivation of allogenecity. Blood. 1996;87:2386-2393.
9. Yajima H, Tomita K, Hitsuda Y. Expression of surface markers on mature monocyte-derived dendritic cells from allergic asthmatics. Yonago Acta Medica. 1999;42:1-10.
10. Romani N, Gruner S, Brang D. Proliferating dendritic cell progenitors in human blood. J Exp Med. 1994;180:83-93.
11. Metlay JP, Witmer-Pack MD, Agger R, Crowley MT, Lawless D, Steinman RM. The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J Exp Med. 1990;171:1753-1771.
12. Egner W, Hart DN. The phenotype of freshly isolated and cultured human bone marrow allostimulatory cells: possible heterogeneity in bone marrow dendritic cell populations. Immunology. 1995;85:611-620.
13. Zhau LJ, Tedder TF. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. Immunology. 1995;154:3821-3835.
14. Tacke F, Randolph GJ. Migratory fate and differentiation of blood monocyte subsets. Immunobiology. 2006;211:609-618.
15. Kramer JL, Baltathakis I, Alcantara SF, Boldt D. Differentation of functional dendritic cells and macrophages from human peripheral blood monocyte precursors is dependent on expression of p21 (WAF1/CIP1) and requires iron. Br J Haematol. 2002;117:727-734.
16. Figdor CG, de Vries IJM, Lesterhuis WJ, Melief CJM. Dendritic cell immunotherapy: mapping the way. Nat Med. 2004;10:475-480.
17. Hoffman CC, Moore KC, Shih CY, Blakley RL. Scanning electron microscopy of human lymphocytes during transformation and subsequent treatment with methotrexate. J Cell Sci. 1977;28:151-165.
18. Zuckerman SH, Ackerman SK, Douglas SD. Long-term human peripheral blood monocyte cultures: establishment, metabolism and morphology of primary human monocyte-macrophage cell cultures. Immunology. 1979;38:401-411.
19. Nguyen XD, Eichler H, Dugrillon A, Piechaczek C, Braun M, Klüter H. Flow cytometric analysis of T cell proliferation in a mixed lymphocyte reaction with dendritic cells. J Immunol Methods. 2003;275:57-68.
20. Köller M, Zwölfer B, Steiner B, Smolen JS, Scheinecker C. Phenotypic and functional deficiencies monocyte-derived dendritic cells in systemic lupus erythematosus (SLE) patients. Int Immunol. 2004;16:1595-1604.
21. Verhaegen S, Coyle S, Connolly LM, O'Loughlin C, Clynes M. Analysis of cell cycle and cell death mechanisms. In: Clynes M, ed. Animal Cell Culture Techniques. Berlin: Springer-Verlag; 1998:170-190.
22. Martinez FO, Gordon S, Locati M, Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol. 2006;15:7303-7311.